Upsher-Smith Announces New Formulation Of B-Nexa® Prescription Vitamin To Help Calm Morning Sickness

News provided by

Sep 11, 2012, 09:39 ET

MAPLE GROVE, Minn., Sept. 11, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the availability of a new formulation of B-Nexa^®Rx Prenatal Vitamin with B Vitamins and Ginger to help calm morning sickness, also known as Nausea and Vomiting of Pregnancy (NVP). The new formulation contains increased amounts of two key ingredients – folic acid and vitamin B6.¹

(Photo: http://photos.prnewswire.com/prnh/20120123/NY39344 )

"It is well recognized that a woman's folate intake before and during early stages of pregnancy is critically important," said Gregory Gilmet, MD, MPH, Senior Medical Director, Medical Affairs, Upsher-Smith Laboratories, Inc.

For the estimated eight out of ten women who experience morning sickness, ensuring that their diet contains an adequate amount of folic acid may be a challenge. B-Nexa^® is an important addition to the prenatal nutrition market. The advanced formulation delivers essential folic acid to help support a healthy pregnancy, especially in the first trimester, while helping to calm morning sickness with ginger and vitamin B6.

The American College of Obstetricians and Gynecologists (ACOG) recommends vitamin B6 as a first-line approach for morning sickness, and also suggests ginger as a non-drug option.² B-Nexa^®'s newest formulation contains 1.22 mg of folic acid and 42 mg of vitamin B6, in addition to ginger.¹

The NDC number for the new formulation of B-Nexa^® is 0245-0215-60. For more information about B-Nexa^®, visit http://www.b-nexa.com.

About NVP

Although commonly known as morning sickness, NVP can occur at any time throughout the day and affects 70 to 85% of pregnant women. Approximately 50% of pregnant women experience both nausea and vomiting, while 25% experience only nausea. Studies have shown that women taking a multivitamin regularly at the time of conception were less likely to have severe cases of NVP.²In most cases, the condition affects women only during the first and early second trimesters, although up to 15% of women continue to have symptoms throughout pregnancy.³

NVP can cause significant distress in many women and can lead to feelings of anxiety about how the fetus may be affected. Some women do not seek treatment for morning sickness because of concerns about drug therapy during pregnancy or because they don't know help is available. Even a less severe case of NVP can detract from the joy of pregnancy and can affect a woman's general well being.⁴

Important Safety Information

You should not take more than 1 mg per day of folic acid unless you are under the care of a healthcare professional, as it may mask the symptoms of a potentially more serious condition.

Taking ginger if you have a bleeding disorder or while you are also taking a blood thinner or other medication that affects the blood may increase the risk of bleeding.

Please see the Full Prescribing Information for a complete list of warnings and precautions. http://b-nexa.com/prescribing-information

About the Nexa^® Family of Products

Upsher-Smith Laboratories, Inc. is committed to providing nutritional support to mothers before, during and after pregnancy. Designed to help support a healthy pregnancy, the Nexa^® family of products includes Nexa^®Plus Capsules (Rx prenatal vitamin with 350 mg plant-based DHA from algal oil), more than any other single gel capsule prescription prenatal vitamin taken once a day,^5-10 Nexa^® Select Capsules (Rx prenatal vitamin with plant-based DHA from algal oil), and PreNexa^®Capsules (Rx prenatal vitamin with plant-based DHA from algal oil), all of which offer essential nutrition for mom and developing baby, including 1.25 mg folic acid. Additionally, B-Nexa^® Tablets (Rx prenatal vitamin formulated with B-vitamins and ginger) are designed to help calm nausea and vomiting of pregnancy while providing important folic acid supplementation. To learn more about the Nexa^® family of products or to obtain complete prescribing information, visit http://www.nexavitamins.com.

About Upsher-Smith Women's Health

Upsher-Smith Women's Health is committed to providing options, specifically designed to meet the ever-changing needs of women throughout their lives, for prenatal nutritional support, bone health support, and symptom relief during menopause. For additional information, visit http://www.upsher-smith.com/products/womens-health.

About Upsher-Smith

Upsher-Smith Laboratories, Inc. is a privately held, U.S.-based company devoted to improving health and advancing wellness since 1919. Upsher-Smith demonstrates its commitment to meeting the healthcare needs of its customers by developing, producing and marketing consumer and prescription products. In addition to its strong heritage in generics, Upsher-Smith's branded businesses focus on women's health, dermatology and CNS therapeutic areas. For additional information, visit http://www.upsher-smith.com.

References

1.	B-Nexa [package insert.] Minneapolis, MN: Upsher-Smith Laboratories, Inc., 2012.
2.	American College of Obstetricians and Gynecologists. ACOG practice bulletin: Nausea and Vomiting of Pregnancy. Obstet Gynecol 2004;103:803–814.
3.	Badell M, Ramin S, Smith J. Treatment Options for Nausea and Vomiting During Pregnancy. Pharmacotherapy. 2006;26(9):1273-1287. Accessed on 10/12/11 at www.medscape.com/viewarticle/545629.
4.	Einarson A, et al. Treatment of Nausea and Vomiting in Pregnancy. Motherisk Update. Canadian Family Physician. December 2007;53:2109-2111.
5.	Nexa Plus [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc., 2012.
6.	CitraNatal Harmony [package insert]. San Antonio, TX: Mission Pharmacal Company; 2010.
7.	Prefera OB ONE [package insert]. Meda Pharmaceuticals Inc.; 2012.
8.	Prenate Essential [package insert]. Avion Pharmaceuticals; 2012.
9.	Vitafol Plus [package insert]. West Orange, NJ: Everett Laboratories, Inc; 2012.
10.	VitaMedMD One Rx product information Web site. http://www.vitamedmdrx.com/SupplementalFactsOneRx.aspx Accessed August 6, 2012.